§ 43-34-26.1 - Influenza vaccine protocol agreements
               	 		
O.C.G.A.    43-34-26.1   (2010)
   43-34-26.1.    Influenza vaccine protocol agreements 
      (a)  As used in this Code section, the term:
      (1)  "Administer"  means the provision of a unit dose of influenza vaccine by a pharmacist  or nurse pursuant to an influenza vaccine order contained in an  influenza vaccine protocol agreement with a physician.
      (2)  "Adverse  event" means an event that is a negative consequence of the  administration of influenza vaccine by a pharmacist or nurse that  results in an unintended reaction, injury, or illness, which may or may  not have been preventable.
      (3)  "Board" means the Georgia Composite Medical Board.
      (4)  "Influenza  vaccine" means an inactivated virus administered by injection or a live  attenuated virus administered by nasal spray that is prepared for the  applicable season and that is administered to produce or increase  immunity to the influenza virus; provided, however, that a live  attenuated virus shall not be administered pursuant to this Code section  to any individual younger than 13 or older than 49 years of age; and  provided, further, that a live attenuated virus shall not be  administered pursuant to this Code section unless the patient or his or  her parent, if a minor, has signed an informed consent that he or she  does not have a contraindication to this vaccine. The informed consent  form shall list the contraindications to the vaccine.
      (5)  "Influenza  vaccine order" means a prescription drug order, contained in an  influenza vaccine protocol agreement, for influenza vaccine issued by a  physician for a group of patients that meet certain criteria and to be  administered by a pharmacist or a nurse. An influenza vaccine order  shall also mean a prescription drug order, contained in an influenza  vaccine protocol agreement, for epinephrine issued by a physician for a  group of patients that meet certain criteria and to be administered by a  pharmacist or a nurse only upon the occurrence of an actual or  perceived anaphylactic adverse reaction to the administered influenza  vaccine provided that the influenza vaccine protocol agreement sets  forth the signs and symptoms that warrant the administration of  epinephrine.
      (6)  "Influenza vaccine  protocol agreement" means a written document mutually agreed upon and  signed by a physician and a pharmacist or by a physician and a nurse, by  which document the physician prescribes influenza vaccine and  epinephrine, if determined appropriate by the physician, by means of an  influenza vaccine order for administration by a pharmacist or a nurse.
      (7)  "Nurse"  means a registered professional nurse as defined in paragraph (9) of  Code Section 43-26-3. The term shall also mean a licensed practical  nurse as defined in paragraph (5) of Code Section 43-26-32 who is  regularly employed by a physician who actively engaged in the private  practice of medicine.
      (8)  "Pharmacist"  means an individual licensed under Chapter 4 of Title 26 to engage in  the practice of pharmacy in the State of Georgia.
      (9)  "Pharmacy intern" means a pharmacy intern as defined in paragraph (19) of Code Section 26-4-5.
      (10)  "Physician"  means an individual licensed to practice medicine and surgery pursuant  to this article and whose principal place of practice is located in this  state.
(b)  A physician engaged in the  active practice of medicine may prescribe influenza vaccine for a group  of patients via an influenza vaccine order contained in an influenza  vaccine protocol agreement to be administered by a pharmacist, provided  the physician is registered with the vaccination registry established by  the Department of Community Health pursuant to Code Section 31-12-3.1,  commonly known as the Georgia Registry of Immunization Transactions and  Services, the pharmacist is located within the county of the physician's  place of registration with the vaccination registry or a county  contiguous thereto, and the pharmacist holds current certification in  Basic Cardiac Life Support and has completed a course of training  accredited by the Accreditation Council for Pharmacy Education or  similar health authority or professional body approved by the Georgia  State Board of Pharmacy. A physician who is a party to an influenza  vaccine protocol agreement may also prescribe epinephrine via an  influenza vaccine order contained in an influenza vaccine protocol  agreement for administration by a pharmacist upon the occurrence of an  actual or perceived anaphylactic adverse reaction to the administered  influenza vaccine provided that the influenza vaccine protocol agreement  sets forth the signs and symptoms that warrant the administration of  epinephrine.
(c)  A physician engaged in the  active practice of medicine may prescribe influenza vaccine for a group  of patients via an influenza vaccine order contained in an influenza  vaccine protocol agreement to be administered by a nurse, provided the  physician is registered with the vaccination registry established by the  Department of Community Health pursuant to Code Section 31-12-3.1,  commonly known as the Georgia Registry of Immunization Transactions and  Services, the nurse is located within the county of the physician's  place of registration with the vaccination registry or a county  contiguous thereto, and the nurse holds current certification in Basic  Cardiac Life Support. A physician who is a party to an influenza vaccine  protocol agreement may also prescribe epinephrine via an influenza  vaccine order contained in an influenza vaccine protocol agreement for  administration by a nurse upon the occurrence of an actual or perceived  anaphylactic adverse reaction to the administered influenza vaccine  provided that the influenza vaccine protocol agreement sets forth the  signs and symptoms that warrant the administration of epinephrine.
(d)  An  influenza vaccine protocol agreement between a physician and a  pharmacist or a physician and a nurse pursuant to this Code section  shall, without limitation:
      (1)  Contain  the current names, addresses, telephone numbers, and professional  license numbers of the physician and the pharmacist or nurse;
      (2)  Contain  a provision for immediate consultation between the pharmacist or nurse  and the physician. If the physician is not available, the physician for  purposes of consultation may designate another physician who concurs  with the terms of the influenza vaccine protocol agreement;
      (3)  Require  the pharmacist or nurse to provide the influenza vaccine recipient with  the appropriate and current Vaccine Information Statement (VIS) as  provided by the federal Centers for Disease Control and Prevention;
      (4)  Require  the pharmacist or nurse or his or her employer to retain documentation  of each dose of influenza vaccine administered. Such documentation shall  include, but not be limited to:
            (A)  The administering pharmacist's or nurse's name, address, telephone number, and professional license number;
            (B)  The name, dose, manufacturer, and lot number of the influenza vaccine;
            (C)  The vaccine recipient's name, address, date of birth, and telephone number;
            (D)  The date of administration and injection site;
            (E)  A  signed and dated consent form by which the vaccine recipient  acknowledges receipt of the VIS and consents to the administration of  the influenza vaccine; and
            (F)  Any adverse events or complications that occur;
      (5)  Require  the pharmacist or nurse to enter the patient's influenza vaccine  information in the Georgia Registry of Immunization Transactions and  Services within the registry's designated time frame, or as designated  by the Department of Community Health;
      (6)  Require,  as a condition of administration of the influenza vaccine, the  influenza vaccine recipient to remain under the observation of the  administering pharmacist or nurse for a period of not less than 15  minutes immediately subsequent to the administration of the influenza  vaccine;
      (7)  Contain procedures to  follow up on the occurrence of an adverse event or complication  including, if prescribed via an influenza vaccine order contained in an  influenza vaccine protocol agreement, the administration of epinephrine;
      (8)  Provide for prioritization of influenza vaccine recipients in the event the supply of influenza vaccine is limited; and
      (9)  Be  renewed and, if necessary, revised or updated biennially by the  physician and the pharmacist or nurse. An influenza vaccine protocol  agreement that is not renewed biennially shall expire.
(e)  A  pharmacist who is a party to an influenza vaccine protocol agreement  pursuant to this Code section shall not delegate the administration of  influenza vaccine to any individual other than a pharmacy intern under  the direct supervision of the pharmacist whether or not any such other  individual is under the supervision, direct or otherwise, of the  pharmacist.
(f)  A nurse who is a party to  an influenza vaccine protocol agreement pursuant to this Code section  shall not delegate the administration of influenza vaccine to any  individual, whether or not any such individual is under the supervision,  direct or otherwise, of the nurse; provided, however, notwithstanding  the requirement of employment by a physician in paragraph (7) of  subsection (a) of this Code section, a registered professional nurse who  is a party to an influenza protocol agreement pursuant to this Code  section may delegate the administration of influenza vaccine to a  licensed practical nurse under the direct on-site supervision of the  registered professional nurse.
(g)  Notwithstanding  any law to the contrary, a nurse acting pursuant to an influenza  vaccine protocol agreement as provided in this Code section may possess  and transport influenza vaccine and epinephrine.
(h)  A  pharmacist or nurse administering influenza vaccines pursuant to an  influenza vaccine protocol agreement authorized by this Code section  shall maintain policies and procedures for the handling and disposal of  used or contaminated equipment and supplies.
(i)  Nothing  in this Code section shall be construed to authorize a physician to  prescribe any vaccines or other drugs pursuant to an influenza vaccine  protocol agreement or influenza vaccine order contained in an influenza  vaccine protocol agreement other than influenza vaccines and  epinephrine.
(j)  A delegating physician may  not enter into an influenza vaccine protocol agreement with more than  ten pharmacists or nurses, or any combination thereof, at any one time;  provided, however, and notwithstanding the geographic limitations  provided in subsections (b) and (c) of this Code section, a delegating  physician may enter into an influenza vaccine protocol agreement with  more than ten pharmacists or nurses, or any combination thereof, at any  one time so long as the pharmacists or nurses are in the same public  health district as established pursuant to Code Section 31-3-15 and are  employees or agents of the same corporate entity.
(k)  It  shall be unlawful for a physician who is employed by a pharmacist or  nurse to enter into an influenza vaccine protocol agreement or otherwise  delegate medical acts to such pharmacist or nurse. It shall be unlawful  for a physician who is employed by a pharmacy to enter into an  influenza vaccine protocol agreement or otherwise delegate medical acts  to a pharmacist or nurse who is also employed by such pharmacy.
(l)  The  board shall have the authority to promulgate rules and regulations  governing a physician who is a party to an influenza vaccine protocol  agreement in order to carry out the intent and purposes of this Code  section. Further, the board shall:
      (1)  Require  that the influenza vaccine protocol agreement be filed by the physician  with the board and be made available by the board for public  inspection; and
      (2)  Promulgate by rule  an approved standard protocol template that may be utilized as an  influenza vaccine protocol agreement and make such template available on  the board's website.
(m)  Nothing in this  Code section shall be construed to require a physician to enter into an  influenza vaccine protocol agreement. A public or private managed care  system, health plan, hospital, insurance company, or similar entity  shall not require a physician, pharmacist, or nurse to enter into an  influenza vaccine protocol agreement as a condition for participation in  or reimbursement from such entity.
(n)  No  physician who complies with the provisions of this Code section shall be  subject to criminal or civil liability or discipline for unprofessional  conduct for:
      (1)  Entering into an influenza vaccine protocol agreement with a pharmacist or nurse;
      (2)  Issuing an influenza vaccine order contained in an influenza vaccine protocol agreement with a pharmacist or nurse; or
      (3)  The  acts or omissions of a pharmacist or nurse pursuant to an influenza  vaccine protocol agreement including the administration of influenza  vaccine or epinephrine.
Nothing in this subsection shall be interpreted as altering liability of an employer for acts of his or her employees.
(o)  This  Code section shall not apply to any activities conducted within a  hospital or within any other facility or entity owned, operated, or  leased by a hospital.
(p)  This Code section  shall not be interpreted as limiting the authority of any authorized  person to dispense or administer influenza vaccine or other medications.
(q)  No  influenza vaccine protocol agreement entered into pursuant to this Code  section shall permit a pharmacist or nurse to administer an influenza  vaccine to any child under the age of 13 without an individual  prescription from a physician, and consent of the child's parent or  legal guardian shall be a condition precedent to the administration of  an influenza vaccine to a child under the age of 18.